Nervous system

Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Disease

Retrieved on: 
Monday, May 21, 2018
Biology, Neuroscience, Nervous system, Anatomy, Neurodegeneration, Senescence, Human brain, Parkinson's disease, Omics, Estrogen and neurodegenerative diseases, Patrik Verstreken

Growing evidence shows that neurodegenerative diseases result from multiple interacting cell types, each of which contributes to disease in a unique manner.

Key Points: 
  • Growing evidence shows that neurodegenerative diseases result from multiple interacting cell types, each of which contributes to disease in a unique manner.
  • Yet, no datasets currently exist that capture gene expression changes across individual cell types in disease patients and healthy controls for any disease.
  • Verge, VIB, and UC San Diego will collaborate to sequence all genes expressed in individual cell nuclei of brain tissue from people with and without neurodegenerative diseases, beginning with Parkinson's disease.
  • Verge Genomics is a next-generation drug discovery company that is using human genomics to accelerate drug discovery.

Cigna Furthers its Commitment to Help Curb the National Opioid Epidemic

Retrieved on: 
Wednesday, May 16, 2018
Pain, Perception, Opioids, Nervous system, Acute pain, Nociception, Morphine, Opioid, Cigna, Analgesic

An estimated 2.5 million people suffer from substance use disorders related to prescription opioid pain relievers in the United States1.

Key Points: 
  • An estimated 2.5 million people suffer from substance use disorders related to prescription opioid pain relievers in the United States1.
  • Cigna has also developed a tool enabling people to determine if a prescription is an opioid or not by entering the name of the medicine on the Help with Pain website.
  • "At Cigna, we focus on preventive care and keeping people healthy," said Stephen Cassell, Vice President, Global Branding at Cigna.
  • Cigna's new pain resource website provides tools for individuals, care providers and employers to help prevent opioid misuse through education.

Revolutionary Neuromodulation Technology Confirmed as Effective Treatment for Diabetic Neuropathy in Interim Study Results

Retrieved on: 
Monday, May 14, 2018
Pain, Perception, Nervous system, Acute pain, Diabetes, Diabetic neuropathy, Peripheral neuropathy

Through attendance, Xavant seeks to gain additional awareness for its Stimpod NMS460 device's treatment solution of Peripheral Diabetic Neuropathy (PDN).

Key Points: 
  • Through attendance, Xavant seeks to gain additional awareness for its Stimpod NMS460 device's treatment solution of Peripheral Diabetic Neuropathy (PDN).
  • The efficacy of the treatment solution provided by the Stimpod NMS460 has stimulated tremendous interest due to a controlled trial study, conducted at the St. Thomas Pain Management Centre in London.
  • The interim results have just been released and the initial findings have been equally significant compared to the findings at St Thomas Pain Management Centre's.
  • Professor Berger will be available to discuss the treatment protocol and the interim study results at the Xavant Technology exhibition at the Diabetologist Conference.

Global Neuropathic Pain Market 2018-2024: Market Remained Stagnant Over Recent Years Due to Lack of Innovation

Retrieved on: 
Monday, May 14, 2018
Pain, Perception, Medicine, Nervous system, Neuropathic pain, Neuralgia, Peripheral neuropathy, Postherpetic neuralgia, EMA401, Chronic wound pain

The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neuropathic Pain Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering.
  • Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory system, resulting in symptoms that include burning, stabbing, shooting, or electric shock-like sensations, which substantially differentiate it from nociceptive pain.
  • Neuropathic pain is not a single disease, but a syndrome caused by an array of different diseases and lesions, with common subtypes such as diabetic peripheral neuropathy, post-herpetic neuralgia, and chemotherapy-induced neuropathic pain.
  • Treatment of neuropathic pain has remained stagnant over recent years due to lack of innovation within the pain market.

Boston TMS Therapy Center Earns NeuroStar® Gold Circle Provider Status

Retrieved on: 
Monday, May 14, 2018
Neuroscience, Psychiatry, Nervous system, Neuropsychology, Neurophysiology, Neurotechnology, Treatment of depression, Neuronetics, Major depressive disorder

BOSTON, May 14, 2018 /PRNewswire/--The TMS Center at Commonwealth Psychology Associates (CPA) is now a Gold Circle Provider of NeuroStar TMS Therapy.

Key Points: 
  • BOSTON, May 14, 2018 /PRNewswire/--The TMS Center at Commonwealth Psychology Associates (CPA) is now a Gold Circle Provider of NeuroStar TMS Therapy.
  • Gold Circle Provider status is earned by TMS centers and doctors who have performed 500 or more treatments in the last 12 months.
  • Chief of Psychiatry Dr. Sanja Petrovic and Dr. Simreet Khaira are Board-certified psychiatrists providing TMS Therapy for Depression at CPA's downtown Boston TMS Center.
  • CPA is proud to be the only private behavioral health practice in the city of Boston to offer NeuroStar TMS Therapy.

Dr. Richard G. Dudley, Jr. is recognized by Continental Who's Who

Retrieved on: 
Friday, May 11, 2018
Psychiatry, Psychiatrist, Dudley, Nervous system, Health

Dr. Dudley currently serves as a private practice psychiatrist with an office located on Manhattan's Upper West Side.

Key Points: 
  • Dr. Dudley currently serves as a private practice psychiatrist with an office located on Manhattan's Upper West Side.
  • Amassing over 40 years of total career experience, his professional focus includes psychiatric therapy for adult men, as well as forensic psychiatry.
  • Throughout his educational career, Dr. Dudley attended Medical school at Temple University's School of Medicine, and graduated with his M.D.
  • In honor of his professional accolades, Dr. Dudley has been recognized as a Healthgrades Honor Roll Physician.

Mounting Stress Left Over From High School Can Wind Up a Financial Burden, Says Ameritech Financial

Retrieved on: 
Friday, May 11, 2018
Stress, Loans, Personal finance, Endocrine system, Sympathetic nervous system, Psychological stress, Psychology, Economy, Student loan, Nervous system

Ameritech Financial, a document preparation service company that assists federal student loan borrowers in applying for available repayment programs, is aware some of the long-term effects that financial stress specifically can inflict on people.

Key Points: 
  • Ameritech Financial, a document preparation service company that assists federal student loan borrowers in applying for available repayment programs, is aware some of the long-term effects that financial stress specifically can inflict on people.
  • Most of the struggles from high school are still relevant to the struggles of college life.
  • There's still family business, maintaining grades in classes, and trying to do some activities outside of school to have fun and relax with.
  • College comes with its own stressors, and many college attendees bring with them stress left over from high school.

Nevro to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

Retrieved on: 
Wednesday, May 2, 2018
Pain, Nervous system, Perception, Neurotechnology, Pain management, Nociception, Neurophysiology, Spinal cord stimulator, Neuromodulation, Chronic pain

REDWOOD CITY, Calif., May 2, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference on Tuesday, May 15, 2018 in Las Vegas.

Key Points: 
  • REDWOOD CITY, Calif., May 2, 2018 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its management will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference on Tuesday, May 15, 2018 in Las Vegas.
  • Nevro management is scheduled to present at 2:20 p.m. PT.
  • Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain.
  • Senza, Senza II, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Rosie Colucci of Palatine, Illinois named one of America's top 10 youth volunteers of 2018

Retrieved on: 
Monday, April 30, 2018
RTT, Neurofibromatosis, Brain tumor, Hydrocephalus, Nervous system, Health, Medicine

Rosie and Kennison were named Illinois's top youth volunteers in February, and were officially recognized last night at the Smithsonian's National Museum of Natural History along with the top two youth volunteers in each other state and the District of Columbia.

Key Points: 
  • Rosie and Kennison were named Illinois's top youth volunteers in February, and were officially recognized last night at the Smithsonian's National Museum of Natural History along with the top two youth volunteers in each other state and the District of Columbia.
  • At 3 years old, she was diagnosed with an inoperable brain tumor, neurofibromatosis and hydrocephalus, along with other life-threatening conditions.
  • During one hospitalization when she was 4, she received so many gifts that her mother said she couldn't possibly take them all home.
  • In the U.S., Prudential's iconic Rock symbol has stood for strength, stability, expertise and innovation for more than a century.

SPLENDA® Naturals Teams Up with We Dare to Bare to Inspire Women to be "Super Natural"

Retrieved on: 
Thursday, April 26, 2018
Sugar substitutes, Food and drink, Perception, Gustatory system, Sensory systems, Nervous system, Splenda, Stevia, Taste, Aftertaste

We Dare to Bare events benefit the Movemeant Foundation , a leading non-profit organization that empowers women and girls by providing body-positive, self-confidence building tools.

Key Points: 
  • We Dare to Bare events benefit the Movemeant Foundation , a leading non-profit organization that empowers women and girls by providing body-positive, self-confidence building tools.
  • With SPLENDA Naturals Stevia Sweetener, people can enjoy the sweet things in life, without the insecurities that sometimes come with them.
  • One-hundred percent natural, SPLENDA Naturals is a great-tasting, no-calorie natural sweetener with no GMO ingredients, no added flavors and no bitter aftertaste.
  • "We are thrilled to have SPLENDA Naturals as a partner to help arm women with the tools to become their best selves."